IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Sitagliptin affect hepatic glucose output during fasting?
Sitagliptin reduces hepatic glucose production by inhibiting DPP-4, which enhances the incretin effect, improving fasting glucose levels in type 2 diabetes.
Sitagliptin reduces hepatic glucose production by inhibiting DPP-4, which enhances the incretin effect, improving fasting glucose levels in type 2 diabetes.
See lessHow does Sitagliptin impact the development of diabetes-related kidney diseases?
Sitagliptin, a DPP-4 inhibitor, may slow the progression of diabetic nephropathy by reducing albuminuria and improving glycemic control, thus potentially preserving renal function.
Sitagliptin, a DPP-4 inhibitor, may slow the progression of diabetic nephropathy by reducing albuminuria and improving glycemic control, thus potentially preserving renal function.
See lessCan Sitagliptin reduce fasting plasma glucose in severely obese diabetics?
Yes, Sitagliptin can effectively reduce fasting plasma glucose levels in severely obese diabetics, and it enhances insulin sensitivity by modulating incretin hormones.
Yes, Sitagliptin can effectively reduce fasting plasma glucose levels in severely obese diabetics, and it enhances insulin sensitivity by modulating incretin hormones.
See lessHow does Sitagliptin compare to GLP-1 receptor agonists in weight management?
Sitagliptin generally leads to less weight loss compared to GLP-1 receptor agonists, which often promote significant weight reduction in obese Type 2 diabetes patients.
Sitagliptin generally leads to less weight loss compared to GLP-1 receptor agonists, which often promote significant weight reduction in obese Type 2 diabetes patients.
See lessCan Sitagliptin improve glycemic control during acute illnesses?
Sitagliptin has not been specifically validated for managing acute hyperglycemia during illness or stress-related glucose spikes.
Sitagliptin has not been specifically validated for managing acute hyperglycemia during illness or stress-related glucose spikes.
See lessHow does Sitagliptin prevent weight loss in malnourished diabetics?
Sitagliptin stabilizes blood glucose by enhancing incretin hormones, which inhibit glucagon release and stimulate insulin secretion, thus improving nutrient utilization and supporting weight maintenance.
Sitagliptin stabilizes blood glucose by enhancing incretin hormones, which inhibit glucagon release and stimulate insulin secretion, thus improving nutrient utilization and supporting weight maintenance.
See lessCan Sitagliptin enhance the effects of dietary interventions in diabetes?
Sitagliptin, by inhibiting DPP-4, enhances incretin hormone activity, which improves beta-cell function and glucose regulation, thus boosting dietary intervention effects in diabetes management.Sitagliptin aids in glucose management in diabetic patients through DPP-4 inhibition which increases increRead more
Sitagliptin, by inhibiting DPP-4, enhances incretin hormone activity, which improves beta-cell function and glucose regulation, thus boosting dietary intervention effects in diabetes management.
Sitagliptin aids in glucose management in diabetic patients through DPP-4 inhibition which increases incretin levels, enhancing the effects of diet-based interventions by improving postprandial glycemic control.
See lessHow does Sitagliptin reduce oxidative damage in high-stress diabetics?
Sitagliptin mitigates oxidative damage in diabetic patients under high stress by enhancing the function of incretin hormones, which improve insulin response and reduce blood glucose levels. This action minimizes oxidative stress and helps in preserving organ tissues.
Sitagliptin mitigates oxidative damage in diabetic patients under high stress by enhancing the function of incretin hormones, which improve insulin response and reduce blood glucose levels. This action minimizes oxidative stress and helps in preserving organ tissues.
See lessHow does Sitagliptin influence lipogenesis in diabetic patients?
Sitagliptin, a DPP-4 inhibitor, enhances GLP-1 levels which reduces lipogenesis and promotes lipolysis, thereby decreasing fat accumulation in diabetics.
Sitagliptin, a DPP-4 inhibitor, enhances GLP-1 levels which reduces lipogenesis and promotes lipolysis, thereby decreasing fat accumulation in diabetics.
See lessCan Sitagliptin prevent the decline of insulin sensitivity in type 2 diabetes?
Sitagliptin primarily enhances insulin secretion rather than preventing insulin sensitivity decline, differing from therapies like metformin which improve insulin sensitivity.
Sitagliptin primarily enhances insulin secretion rather than preventing insulin sensitivity decline, differing from therapies like metformin which improve insulin sensitivity.
See less